Join Our 20,000+ Subscribers. Get Weekly News Sent To Your Email
Subscribe to our newsletter and stay updated on the latest Critical Care Medicine related news.
See Past Critical Care Newsletter issues

Subscribe to Newsletter

Frontline PARP inhibitor shrinks tumors in BRCA-positive breast patients

medicalxpress.com October 5, 2016

All 13 newly diagnosed breast cancer patients with BRCA mutations had their tumors shrink significantly when treated with a PARP inhibitor ahead of frontline presurgical chemotherapy in a pilot study at The University of Texas MD Anderson Cancer Center.

cancer chemotherapy oncology study tumors ultrasound

Prognostic Predictor Using Lactate-to-Albumin Ratio in Patients with Cirrhosis and Sepsis

Non-invasive ICP Monitoring for TBI Patients When Invasive Systems Not Available

POCUS-first vs. CT-first Approach on ED LOS in Patients with Acute Cholecystitis

Mortality Predictor with sPAP in Elderly Critically Ill with Severe COVID-19 Pneumonia

Clinical Companion in Nephrology

Clinical Pharmacokinetics and Pharmacodynamics

MRSA Protocols – Methods in Molecular Biology

Prediction and Management of Severe Acute Pancreatitis

The Only EKG Book You’ll Ever Need

Infectious Diseases A Clinical Short Course

Endovascular Resuscitation and Trauma Management

ICU Protocols: A Step-wise Approach, Vol II

Sepsis: Clinical Diagnosis and Treatment

Fast-Track in Cardiac Anesthesia: Cardiac Surgery in the Era of ERAS

COVID-19 and the Cardiovascular System: From Pathophysiology to Clinical Management

Ethics in Intensive Care Medicine (Lessons from the ICU)

The Infectious Disease Diagnosis: A Case Approach

Mechanical Ventilation in Patient with Respiratory Failure